NIRMAN AGRI GENETICS
Back to Balance Sheet
|
NIRMAN AGRI GENETICS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3.14 Cr | ₹6.88 Cr | ₹2.14 Cr | ₹2.07 Cr | ₹0.58 Cr |
What is the latest Total Current Liabilities ratio of NIRMAN AGRI GENETICS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹3.14 Cr |
| Mar2024 | ₹6.88 Cr |
| Mar2023 | ₹2.14 Cr |
| Mar2022 | ₹2.07 Cr |
| Mar2021 | ₹0.58 Cr |
How is Total Current Liabilities of NIRMAN AGRI GENETICS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.14 Cr | -54.45 | |
| Mar2024 | ₹6.88 Cr | 221.29 | |
| Mar2023 | ₹2.14 Cr | 3.58 | |
| Mar2022 | ₹2.07 Cr | 254.11 | |
| Mar2021 | ₹0.58 Cr | - | |
Compare Total Current Liabilities of peers of NIRMAN AGRI GENETICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NIRMAN AGRI GENETICS | ₹38.6 Cr | -11.3% | -27.4% | -87.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,089.0 Cr | -6.1% | -9% | -14.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,131.8 Cr | -9.7% | -13.7% | -8.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,048.0 Cr | -6.5% | 3.4% | -15.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹972.4 Cr | -6.9% | -7.9% | -32.7% | Stock Analytics | |
| INDO US BIOTECH | ₹224.8 Cr | -1.9% | -9% | -53.1% | Stock Analytics | |
NIRMAN AGRI GENETICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NIRMAN AGRI GENETICS | -11.3% |
-27.4% |
-87.3% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses